We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+10.14%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$116M
AUM Growth
+$19.2M
Cap. Flow
+$6.29M
Cap. Flow %
5.4%
Top 10 Hldgs %
65.75%
Holding
56
New
8
Increased
9
Reduced
8
Closed
10

Top Buys

Rank Stock Value
1
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$9.46M
2
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
+$4.24M
3
GLMD icon
Galmed Pharmaceuticals
GLMD
+$2.63M
4
ATRC icon
AtriCure
ATRC
+$2.34M
5
VXRT
Vaxart
VXRT
+$2.26M

Top Sells

Rank Stock Value
1
GIVN
GIVEN IMAGING LTD
GIVN
+$4.7M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$2.56M
3
STXS icon
Stereotaxis
STXS
+$1.74M
4
RIOT icon
Riot Platforms
RIOT
+$1.33M
5
ACHV icon
Achieve Life Sciences
ACHV
+$928K

Sector Composition

Rank Sector Weight
1 Healthcare 70.62%
2 Financials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYAX
51
DELISTED
DYAX CORPORATION
DYAX
– –
-75,500
Closed -$569K
BAXS
52
DELISTED
BAXANO SURGICAL INC COM STK (DE)
BAXS
– –
-336,351
Closed -$340K
GIVN
53
DELISTED
GIVEN IMAGING LTD
GIVN
– –
-156,320
Closed -$4.7M
1 2
3

Similar funds

CDMG
Creek Drive Management Group San Francisco, California $439M AUM
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
WAS
Winch Advisory Services Appleton, Wisconsin $438M AUM 17.59% 1-Year Est. Return

DAFNA Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, DAFNA Capital Management held 56 positions worth $116M, up 20% from $97.2M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

DAFNA Capital Management deployed $6.29M of net new capital in Q1 2014, opening 8 new positions and adding to 9 existing holdings. Its largest new stake was Galmed Pharmaceuticals: 1,123 shares worth $2.32M.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 57% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Intercept Pharmaceuticals, Inc., an estimated $2.56M trimmed.

  • DAFNA Capital Management's largest Q1 2014 buy was Galmed Pharmaceuticals: 1,123 shares worth $2.32M.
  • DAFNA Capital Management added most to Ampio Pharmaceuticals Inc. in Q1 2014, an estimated $9.46M increase.
  • DAFNA Capital Management's biggest Q1 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $2.56M.
  • DAFNA Capital Management fully exited GIVEN IMAGING LTD in Q1 2014, selling an estimated $4.7M.
  • DAFNA Capital Management's ten largest holdings make up 66% of its $116M portfolio in Q1 2014.
  • DAFNA Capital Management opened 8 new positions and closed 10 in Q1 2014.
  • DAFNA Capital Management's portfolio value rose 20% quarter-over-quarter to $116M.

Based on DAFNA Capital Management's 13F filing for Q1 2014, filed 15 May 2014.